Kura Oncology Inc.
Kura Oncology is a San Diego‑based clinical‑stage biopharma focused on solid and leukemic cancers, with a pipeline of potent oral agents (tipifarnib, ziftomenib, KO‑2806) and strategic collaborations with Novartis, Kyowa Kirin and Mirati.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Hospitals and Health Care
- Industry: Medical Practices
- Employees: 192
- HQ: San Diego
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.